Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients

Autor: Gideon M. Hirschfield, Femi Adekunle, Marco Carbone, Olivier Chazouillères, Helena Cortez-Pinto, Guilherme Macedo, Victor de Ledinghen

Publikováno v: Expert Review of Gastroenterology & Hepatology
Expert Review of Gastroenterology & Hepatology, Future Drugs, 2007-, 2021, pp.1-11. ⟨10.1080/17474124.2021.1945919⟩
Expert Review of Gastroenterology & Hepatology, 2021, pp.1-11. ⟨10.1080/17474124.2021.1945919⟩

© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6548d79972a10c5311e81e29090fbf
https://doi.org/10.1080/17474124.2021.1945919

Transforming HCV Management

Autor: Graham Foster, Patrick Marcellin, Ira Jacobson, Heiner Wedemeyer, Christophe Hézode, Antonio Craxì

Publikováno v: European Medical Journal Hepatology, Vol 2, Iss 1, Pp 36-41 (2014)

This Gilead-sponsored satellite symposium addressed the new and exciting advent of novel therapy in the field of hepatitis C by highlighting recent important clinical trials. The scientific programme covered the history of treatment of hepatitis C an

Externí odkaz: https://doaj.org/article/8d9f5b29724c437eb4e675a4110fe2b7

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

Autor: Sébastien Michel, Mustapha Najimi, Yelena Vainilovich, Virginie Barthel, Luc L. Lasser, Victor Vargas, Desislava Lyubomirova, Agustín Albillos, Etienne Sokal, Noelia Gordillo, Nathalie Clerget-Chossat, Frederik Nevens, Pierre-François Laterre, Lyudmil E. Haralampiev, Thierry Gustot, Ivaylo Stoykov

Publikováno v: JHEP Reports
JHEP Reports, 3 (4
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
JHEP Reports, Vol 3, Iss 4, Pp 100291-(2021)
JHEP Reports, Vol. 3, no. 4, p. 100291 [1-10] (2021)

Background & Aims: Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21f831201daccbe657298e10bc15d2
https://lirias.kuleuven.be/handle/123456789/677657

Non-alcoholic fatty liver disease: A patient guideline

Autor: Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley

Publikováno v: JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawarene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1
https://pubmed.ncbi.nlm.nih.gov/34693236